PCRX
Pacira BioSciences, Inc.
25.20$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.2% | 26.3% | 28.4% | 24.9% | 23.1% | 21.3% | 20.3% | 22.6% | 19.1% | 20.5% | 20.5% | 23.0% | 20.8% | |
| 75.8% | 73.7% | 71.6% | 75.1% | 76.9% | 78.7% | 79.7% | 77.4% | 80.9% | 79.5% | 79.5% | 77.0% | 79.2% | |
| 12.7% | 10.7% | 10.9% | 11.4% | 11.3% | 12.8% | 15.0% | 15.6% | 14.5% | 19.0% | 15.8% | 15.7% | 16.3% | |
| 18.1% | 16.6% | 19.5% | 16.3% | 18.5% | 15.6% | 18.5% | 20.8% | 18.6% | 20.3% | 20.2% | 47.7% | 26.9% | |
| 64.9% | 55.4% | 63.7% | 59.3% | 159.7% | 65.5% | 78.5% | 72.7% | 77.4% | 77.9% | 76.9% | 74.8% | 76.7% | |
| 10.8% | 18.3% | 7.9% | 15.9% | -82.8% | 13.2% | 1.2% | 4.7% | 3.5% | 1.6% | 2.6% | 2.2% | 2.5% | |
| 2.1% | 1.9% | 2.0% | 1.8% | 2.8% | 2.0% | 2.7% | 2.6% | 2.0% | 1.7% | 1.8% | 1.9% | 1.9% | |
| 10.1% | 18.6% | 8.2% | 20.6% | -82.4% | 13.6% | 5.2% | -1.1% | 5.3% | 0.3% | 2.8% | 1.3% | 2.4% | |
| 3.5% | 4.9% | 2.8% | 9.9% | 2.7% | 5.1% | 2.3% | 1.6% | 2.3% | -0.5% | 1.2% | -1.1% | 0.4% | |
| 6.6% | 13.7% | 5.4% | 10.6% | -85.1% | 8.6% | 2.8% | -2.7% | 3.0% | 0.8% | 1.6% | 2.4% | 2.0% | |
| 23.1% | 30.3% | 20.8% | 32.9% | -68.1% | 27.0% | 19.9% | 16.1% | 19.1% | 12.8% | 16.6% | 13.3% | 15.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.